Susquehanna Fundamental Investments, LLC Caribou Biosciences, Inc. Call Options Transaction History
Susquehanna Fundamental Investments, LLC
- $2.14 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CRBU
# of Institutions
159Shares Held
67.5MCall Options Held
111KPut Options Held
105K-
Black Rock Inc. New York, NY7.01MShares$16 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA6.48MShares$14.8 Million1.64% of portfolio
-
State Street Corp Boston, MA6.35MShares$14.5 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX5.79MShares$13.2 Million1.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.11MShares$9.41 Million0.0% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $139M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...